SOLICITATION NOTICE
66 -- Multi species Hematology System
- Notice Date
- 8/24/2022 8:38:37 AM
- Notice Type
- Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NHLBI BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- NHLBI-22-016942
- Response Due
- 9/6/2022 2:00:00 PM
- Archive Date
- 09/21/2022
- Point of Contact
- Trevin Skeens, Phone: 3018274016
- E-Mail Address
-
tskeens@nih.gov
(tskeens@nih.gov)
- Description
- Example item list from requested machine below. QTY. 1 Multi species Analyzer QTY. 1 HFRO Key (add on) optional (installed) QTY. 1 HVDMS Interface Software for Excel Spreadsheet on host Computer (included) QTY. 1�Laser Jet or Equivalent Printer� QTY. 1 Start-up Reagent Kit QTY. 1 Alpha/Numeric ID keyboard QTY. 1 Serial interface port and interface specifications QTY. 150 specimen data storage QTY. 1 Full-Year Warranty on all Parts and Labor QTY. 1 Virtual installation Included Shipping & Handling Statement of Need/Purpose and Objectives The Laboratory of Vascular Inflammation and Thrombosis (LVTI) within the Translational Vascular Medicine Branch (TVMB) is currently in need of a blood cell analyzer for determining differential blood counts in non-coagulated whole blood from patient and rodent blood samples. The LVTI regularly performs experiments on rodent models to look at the contribution of various genes to thrombosis and inflammation and explore strategies to mitigate any adverse effects. During these studies in animal models, the differential blood counts in systemic circulation might get altered. Determining the differential blood count is therefore important to understand the role of gene(s) being investigated in maintaining homeostasis. LVTI also systematically evaluates blood cells in patient�s blood samples for evidence of activation that may contribute to thrombosis and inflammation. Determining blood cell counts in patient samples helps us to determine the volume of patient blood sample needed for an ex vivo experiment. Measuring the differential blood counts is thus essential in determining the physiological impact of genes/proteins in rodent experiments and to effectively accomplish the goals of an ex vivo experiment performed with limited patient samples. The objective of this purchase is to procure a blood cell analyzer in support of these studies that are aligned with the goals of the LVTI and mission critical for the NHLBI and NIH. Product Specifications/Features/Salient Characteristics Key characteristics essential for the blood cell analyzer system are as follows: 1. Must be able to determine the differential blood count for human, mouse and rat samples. 2. Must have dedicated pre-programmed species keys for human, mouse and rat samples. 3. Must be fast enough to process up to 25 samples per hour. 4. Must have an extended operating range to ensure accuracy for samples with very high cell counts.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/f8f6f3a729264709a1d84a6c9b022e22/view)
- Place of Performance
- Address: Bethesda, MD 20892, USA
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN06439428-F 20220826/220824230124 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |